KKR vs CME Group

This page compares KKR & Co. L.P. and CME Group Inc., examining their business models, financial performance, and market context for stock market participants. The content is designed to be neutral, accessible, and informative. Educational content, not financial advice.

This page compares KKR & Co. L.P. and CME Group Inc., examining their business models, financial performance, and market context for stock market participants. The content is designed to be neutral, a...

Comparison Snapshot

Key Financial Metrics

KKR

Metric

CME

$90.68B

Market Cap

$109.29B

57.44%

Potential Profit

-6.15%

Buy

Analyst Rating

Hold

Why It's Moving

KKR Director's Bold $5.2M Share Buy Signals Insider Confidence Amid Revenue Surge

Insider purchase by Timothy Barakett at $105 per share reflects belief in KKR's growth trajectory despite recent net insider selling over the past year.
Q4 revenue exploded to $5.93 billion from $2.23 billion expected, driven by alternative asset management strength and signaling robust capital deployment.
Recent analyst upgrades, including Oppenheimer's $187 target, align with KKR's positive 2026 private markets outlook emphasizing resilient portfolios and mega themes like AI energy demands.

Sentiment:

🐃Bullish

CME Stock Warning Overstated: Record Highs and Earnings Beats Counter Analyst Downside Fears

Q4 revenue hit $1.65B, topping $1.64B forecasts by 8.1% year-over-year, driven by record volumes in metals, Bitcoin futures, and S&P 500 E-mini contracts that underscore CME's grip on high-volatility trading.
Earnings per share reached $2.77 versus $2.75 expected, with management spotlighting new 'event contracts' and booming retail sales in micro products to diversify revenue streams.
Announced $6.15 annual variable dividend plus $1.30 Q1 payout—totaling ~$4B for 2025 at 4.2% yield—while planning summer launch of single-stock futures on top names like NVIDIA and Tesla for capital-efficient exposure.

Sentiment:

🐃Bullish

KKR Director's Bold $5.2M Share Buy Signals Insider Confidence Amid Revenue Surge

Insider purchase by Timothy Barakett at $105 per share reflects belief in KKR's growth trajectory despite recent net insider selling over the past year.
Q4 revenue exploded to $5.93 billion from $2.23 billion expected, driven by alternative asset management strength and signaling robust capital deployment.
Recent analyst upgrades, including Oppenheimer's $187 target, align with KKR's positive 2026 private markets outlook emphasizing resilient portfolios and mega themes like AI energy demands.

Sentiment:

🐃Bullish

CME Stock Warning Overstated: Record Highs and Earnings Beats Counter Analyst Downside Fears

Q4 revenue hit $1.65B, topping $1.64B forecasts by 8.1% year-over-year, driven by record volumes in metals, Bitcoin futures, and S&P 500 E-mini contracts that underscore CME's grip on high-volatility trading.
Earnings per share reached $2.77 versus $2.75 expected, with management spotlighting new 'event contracts' and booming retail sales in micro products to diversify revenue streams.
Announced $6.15 annual variable dividend plus $1.30 Q1 payout—totaling ~$4B for 2025 at 4.2% yield—while planning summer launch of single-stock futures on top names like NVIDIA and Tesla for capital-efficient exposure.

Sentiment:

🐃Bullish

Investment Analysis

KKR

Pros

KKR reported strong Q3 2025 earnings, exceeding both EPS and revenue forecasts with robust growth in fee-related earnings.
The firm achieved record fundraising and expanded its presence in high-growth areas such as private credit and Asian markets.
KKR's acquisition of OSTTRA enhances its infrastructure and technology offerings, broadening its alternative asset management platform.

Considerations

Despite strong results, KKR's stock has shown volatility and underperformed in pre-market trading, reflecting investor caution.
The company trades at a high valuation multiple, which may limit upside and increase sensitivity to market sentiment.
KKR's earnings are closely tied to fundraising cycles and capital markets activity, making them vulnerable to economic downturns.

CME Group

CME

Pros

CME Group maintains a dominant position in global derivatives trading, benefiting from high trading volumes and market resilience.
The company generates stable, recurring revenue from clearing and exchange fees, supporting strong cash flow generation.
CME Group has a robust balance sheet and a history of returning capital to shareholders through dividends and buybacks.

Considerations

CME Group's growth is limited by market saturation and regulatory scrutiny in the exchange sector.
Revenue is sensitive to interest rate changes and macroeconomic conditions, which can impact trading activity.
The company faces increasing competition from alternative trading platforms and fintech disruptors.

Related Market Insights

Wall Street's Deal Architects: The M&A Boom Beneficiaries

The M&A market is surging, creating huge fee opportunities for Wall Street's deal architects. Discover how investment banks & advisory firms profit from this boom. Invest with Nemo.